These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7939730)

  • 1. Should methotrexate be used to treat early rheumatoid arthritis?
    Furst DE
    Semin Arthritis Rheum; 1994 Jun; 23(6 Suppl 2):39-43. PubMed ID: 7939730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic suppression of leukotriene B4 synthesis ex vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexate.
    Sperling RI; Benincaso AI; Anderson RJ; Coblyn JS; Austen KF; Weinblatt ME
    Arthritis Rheum; 1992 Apr; 35(4):376-84. PubMed ID: 1314609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Weekly low-dose methotrexate in rheumatoid arthritis. Review of the literature].
    Manganelli P; Troise Rioda W
    Minerva Med; 1993 Oct; 84(10):541-52. PubMed ID: 8247309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis?
    Pincus T; Bergman MJ; Yazici Y
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S82-93. PubMed ID: 26472658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.
    Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM
    Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.
    Varani K; Massara A; Vincenzi F; Tosi A; Padovan M; Trotta F; Borea PA
    Arthritis Rheum; 2009 Oct; 60(10):2880-91. PubMed ID: 19790066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis.
    Milic V; Jekic B; Lukovic L; Bunjevacki V; Milasin J; Novakovic I; Damnjanovic T; Popovic B; Maksimovic N; Damjanov N; Radunovic G; Pejnovic N; Krajinovic M
    Clin Exp Rheumatol; 2012; 30(2):178-83. PubMed ID: 22324981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of leukotriene B4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate.
    Sperling RI; Coblyn JS; Larkin JK; Benincaso AI; Austen KF; Weinblatt ME
    Arthritis Rheum; 1990 Aug; 33(8):1149-55. PubMed ID: 2167685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose oral methotrexate in rheumatoid arthritis: an uncontrolled trial and review of the literature.
    Groff GD; Shenberger KN; Wilke WS; Taylor TH
    Semin Arthritis Rheum; 1983 May; 12(4):333-47. PubMed ID: 6348949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review.
    Wang W; Zhou H; Liu L
    Eur J Med Chem; 2018 Oct; 158():502-516. PubMed ID: 30243154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate pharmacogenetics in rheumatoid arthritis: a status report.
    Malik F; Ranganathan P
    Pharmacogenomics; 2013 Feb; 14(3):305-14. PubMed ID: 23394392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate in rheumatoid arthritis. An update.
    Bannwarth B; Labat L; Moride Y; Schaeverbeke T
    Drugs; 1994 Jan; 47(1):25-50. PubMed ID: 7510620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting.
    Alten R; Burkhardt H; Feist E; Krüger K; Rech J; Rubbert-Roth A; Voll RE; Elbez Y; Rauch C
    Arthritis Res Ther; 2018 Jan; 20(1):1. PubMed ID: 29329602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate use in rheumatoid arthritis. A Clinician's perspective.
    Alarcón GS
    Immunopharmacology; 2000 May; 47(2-3):259-71. PubMed ID: 10878293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rheumatoid arthritis, methothrexate, and pulmonary fibrosis: which evidences?].
    Schaller D; Nendaz M; Gabay C
    Rev Med Suisse; 2010 Mar; 6(240):547-8, 550, 552-4. PubMed ID: 20408459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of inhibition of a catabolic pathway of methotrexate metabolism in its efficacy for rheumatoid arthritis.
    Morgan SL; Baggott JE
    Med Hypotheses; 2019 Jan; 122():10-15. PubMed ID: 30593388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate: new mechanisms and old toxicities.
    Furst DE
    Agents Actions Suppl; 1993; 44():131-7. PubMed ID: 8396846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis.
    Li X; Hu M; Li W; Gu L; Chen M; Ding H; Vanarsa K; Du Y
    Int Immunopharmacol; 2016 Sep; 38():8-15. PubMed ID: 27233001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug combinations with methotrexate to treat rheumatoid arthritis.
    Rath T; Rubbert A
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S52-7. PubMed ID: 21044434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate: the emerging drug of choice for serious rheumatoid arthritis.
    Salach RH; Cash JM
    Clin Ther; 1994; 16(6):912-22; discussion 911. PubMed ID: 7697687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.